Wird geladen...
Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease
BACKGROUND: Individuals with chronic bronchitis or chronic obstructive pulmonary disease (COPD) may suffer recurrent exacerbations with an increase in volume or purulence of sputum, or both. Personal and healthcare costs associated with exacerbations indicate that therapies that reduce the occurrenc...
Gespeichert in:
| Veröffentlicht in: | Cochrane Database Syst Rev |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2019
|
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6527426/ https://ncbi.nlm.nih.gov/pubmed/31107966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001287.pub6 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|